Ebrahim Versi - Sep 15, 2023 Form 4 Insider Report for DMK PHARMACEUTICALS Corp (ADMP)

Signature
/s/ David J. Marguglio, as Attorney-in-Fact for Ebrahim Versi
Stock symbol
ADMP
Transactions as of
Sep 15, 2023
Transactions value $
$0
Form type
4
Date filed
9/19/2023, 05:17 PM
Previous filing
May 30, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ADMP Common Stock Conversion of derivative security $0 +729K +411.53% $0.00 906K Sep 15, 2023 By Versi Group LLC F1, F2
holding ADMP Common Stock 8.75K Sep 15, 2023 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ADMP Series E Convertible Preferred Stock Conversion of derivative security $0 -729 -37.56% $0.00 1.21K Sep 15, 2023 Common Stock 729K By Versi Group LLC F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On September 15, 2023, Versi Group, LLC converted 729.2 shares of Series E Convertible Preferred Stock ("Series E Preferred") into 729,200 shares of Common Stock, pursuant to the terms of the Series E Preferred. Each share of Series E Preferred is convertible into 1,000 shares of Common Stock at the election of the reporting person, subject to certain beneficial ownership limitations. The Series E Preferred has no expiration date.
F2 The reported shares are owned directly by Versi Group, LLC, of which the reporting person is the manager and a member. The reporting person disclaims beneficial ownership of the reported securities, except to the extent of his pecuniary interests therein.